The first participant in a new trial phase recently received a dose of a vaccine candidate against chikungunya disease that…
Shortly after the terrorist events of Sept. 11, 2001, letters containing deadly anthrax spores arrived at locations across the country,…
According to the latest annual report from the global nonprofit partnership CARB-X, at the close of its fifth fiscal year…
The World Health Organization (WHO) has recommended the first vaccine to treat malaria in children, a mosquito-borne disease that kills…
In a new report issued this week, the Bipartisan Commission on Biodefense warned that the United States needs to protect…
The United States Department of Defense (DoD) awarded an agreement worth approximately $22 million to the biopharmaceutical developer Dynavax Technologies…
A bill introduced last week by U.S. Sen. Jim Risch (R-ID), the Biological Weapons Policy Act (S. 2912), seeks to…
An ages-old issue may be on the road to modern solutions, thanks to a new collaboration between the Biomedical Advanced…
With a pair of new bills this week, United States Rep. Eric Swalwell (D-CA) sought to improve the federal government’s…
The fourth implementation phase of the Biomedical Advanced Research and Development Authority’s (BARDA) Transatlantic Taskforce for Antimicrobial Resistance (TATFAR) began…
This website uses cookies.